DEF 14A: Evergreen Corporation Seeks Shareholder Approval for Extension to Complete Business Combination

Evergreen Corporation is requesting shareholder approval to extend the deadline for completing a business combination by up to six months, from February 11, 2025, to August 11, 2025.

Summary

• Evergreen Corporation (EVGR) is seeking shareholder approval to extend the period to complete a business combination from February 11, 2025, to August 11, 2025.
• The company intends to amend its Amended and Restated Articles of Association and its investment management trust agreement to allow for this extension.
• The extension can be implemented up to six times, each for an additional month.
• For each one-month extension, the company will deposit the lesser of $80,000 or $0.04 per Class A ordinary share into the trust account.
• The company is in a definitive agreement with Forekast Limited for a proposed business combination, but believes more time is needed to complete the process.
• Shareholders can redeem their Ordinary Shares in connection with the Extraordinary General Meeting; the redemption price was approximately $11.95 per share on January 13, 2025.
• If the extension is not approved, the company will liquidate, redeeming all Public Shares at a per-share price equal to the amount in the trust account, which was approximately $55,779,792.88 as of January 13, 2025.
• The initial shareholders have agreed to vote in favor of the extension.
• The initial shareholders waived their rights to participate in any liquidating distribution with respect to the 2,875,000 Founder Shares and 532,500 shares underlying the private placement units held by them.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company is seeking an extension, which can be seen as a sign of difficulty in closing a deal, they have a definitive agreement in place and are taking steps to ensure they have enough time to complete the transaction. The option for shareholders to redeem their shares provides some downside protection.

Positives

• The extension provides additional time to complete the proposed business combination with Forekast Limited.
• Shareholders have the option to redeem their shares if they do not support the extension.
• The initial shareholders are aligned with the company's goal of completing a business combination and are voting in favor of the extension.
• The company has already entered into a definitive agreement with Forekast Limited.

Negatives

• If the extension is not approved, the company will be forced to liquidate.
• Shareholders who redeem their shares will not participate in any potential future growth of the combined company.
• The market price of the Public Shares on Nasdaq on January 13, 2025 was $11.91, which is $0.04 less per share than the redemption price of approximately $11.95.

Risks

• There is a risk that the business combination with Forekast Limited may not be completed even with the extension.
• The company cannot assure shareholders that they will be able to sell their Ordinary Shares in the open market.
• If the company is deemed to be an investment company for purposes of the Investment Company Act of 1940, it may be forced to liquidate.
• The proposed business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.
• If the company does not complete a business combination within 36-months of its initial public offering, its securities will be suspended from trading and delisted from Nasdaq.

Future Outlook

The company intends to continue seeking a business combination until the Extended Date if the extension is approved. If the extension is not approved, the company will liquidate.

Management Comments

• The board of directors believes that there will not be sufficient time before February 11, 2025 to hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination.
• The board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from February 11, 2025 to the Extended Date.
• EVGR believes a Business Combination will provide significant benefits to its shareholders.

Industry Context

This announcement is typical for SPACs approaching their deadline to complete a business combination. Seeking extensions is a common strategy to provide more time to find and close a deal, but it also introduces the risk of liquidation if shareholders do not approve the extension.

Comparison to Industry Standards

• The redemption price of approximately $11.95 per share is typical for SPACs, reflecting the pro rata share of the trust account.
• The extension payment of the lesser of $80,000 or $0.04 per share is within the range of what other SPACs have offered for monthly extensions.
• Companies like Gores Guggenheim, Inc. (GGPI) and Digital World Acquisition Corp. (DWAC) have also sought extensions to complete their business combinations, highlighting the challenges in the current SPAC market.
• The number of redemptions is a key metric to watch, as high redemptions can reduce the cash available for the business combination and impact the combined company's future prospects.

Stakeholder Impact

• Shareholders have the opportunity to vote on the extension and redeem their shares if they do not support it.
• Employees of Evergreen Corporation and Forekast Limited are impacted by the uncertainty surrounding the completion of the business combination.
• The outcome of the vote impacts the potential for future growth and value creation for shareholders.

Next Steps

• Shareholders will vote on the extension amendment proposal, the trust agreement amendment proposal, and the adjournment proposal at the Extraordinary General Meeting on January 28, 2025.
• If the extension is approved, the company will continue to seek to complete a business combination with Forekast Limited.
• The company intends to call an additional extraordinary general meeting of its shareholders to approve a Business Combination at a future date.

Key Dates

Keywords

business combination, extension, redemption, Forekast Limited, shareholders, liquidation, trust account, amendment, EVGR, SPAC